The Valley Desk

ArticleAdvances in therapyPublished

Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, with Drexel University linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Advances in therapy
Published
Subject terms
Humans; Arthritis, Psoriatic; Interleukin-17; Injections, Subcutaneous; Retrospective Studies; Adult; Aged; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized; Persistence
PubMed ID
39621228
PubMed Central ID
PMC11787232
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal